New Delhi: The Indian Pharmacopoeia Commission (IPC), a body under the health ministry, has named five lifesaving drugs as having shown serious side effects. The drugs are Metronidazole, an antibiotic; Luliconazole, an antifungal; Dalteparin, used for cancer treatment; diabetics drug Gliclazide and Tramadol, a painkiller. During a recently conducted analysis of adverse drug reactions (ADRs),…
New Delhi: Small pharma companies can file an online application if they want to take one more year to comply with global good manufacturing practices (GMPs), the Drugs Controller General of India (DCGI) said. The application has to be submitted through the Online National Drugs Licensing System (ONDLS) portal as no hard copy application will…
The Central Drugs Standard Control Organisation (CDSCO), headed by the Drugs Controller General of India (DCGI), will do the checks to review the compliance status of MSME drug firmsâ good manufacturing practices (GMP), the people added. âRight now, DCGI is still getting applications as the deadline is open,” the first official said. âOnly after the…
New Delhi: The government body charged with setting quality standards for drugs has launched a review of the safety and efficacy norms for 13 commonly used but âvery oldâ drugs and asked pharmaceutical companies to submit their manufacturing licence approval letters. The Indian Pharmacopoeia Commission (IPC), part of the Drugs Controller General of India, said…
New Delhi: The Indian Council of Medical Research (ICMR) and Central Drugs Standard Control Organisation (CDSCO) have developed a test for identifying antimicrobial pathogens and susceptibility to antimicrobial resistance among patients. This will help innovators and testing laboratories in performing rapid diagnostic tests. Antimicrobial resistance (AMR) threatens the efficacy of many life-saving antibiotics and medicines….
Image for representational purposes only. The Drugs Controller General of India (DCGI) has given its final approval for ENTOD Pharmaceuticals PresVu eye drops specifically developed to reduce dependency on reading glasses for individuals affected by presbyopia, a common age-related vision condition that typically impacts those over 40. The approval follows an earlier recommendation by the…
New Delhi: The top drug regulator is planning to direct all drug makers to upload formulation details along with the brand names on its Sugam portal to check the problem of drugs having similar brand names. The Central Drugs Standard Control Organization (CDSCO)’s plan involves asking State Licensing Authorities (SLAs) to check the database before…
